A Harvard University-designed soft robotic exosuit that helped stroke patients walk better could do the same for Parkinson’s and multiple…
Articles by Patricia Inácio, PhD
Prexton Therapeutics has initiated a new Phase 2 clinical trial to assess the safety and effectiveness of its investigational therapy Foliglurax (PXT002331)…
International Stem Cell Corp. (ISCO) says two of its biggest achievements in the last quarter of 2016 was demonstrating that…
Scientists have developed a new computer-based method that shows great promise in improving the accuracy of diagnosis of neurodegenerative diseases, including Alzheimer’s…
Researchers have identified a gene that acts as a switch for genes regulating mitochondria metabolism in neurons. These findings suggest that…
A biomarker usually measured in the cerebrospinal fluid (CSF) and used to differentiate Parkinson’s disease (PD) from similar diseases, has been…
Axovant Sciences has announced the preliminary results of a Phase 2 clinical trial testing the investigational oral drug therapy nelotanserin…
Researchers have discovered that a protein called Nrf2 is capable of maintaining healthy levels of certain proteins linked to Parkinson’s…
An international post-mortem brain study of Parkinson’s disease shows altered levels of the LRRK2 protein are associated with different stages…
Disruption of the brain’s structural network has been identified as the potential underlying mechanism for the onset of mild cognitive…